Medical device manufacturing company Rhythmlink International, LLC announced a new patent licensing agreement with Dignity Health “that includes broad coverage for improving and expanding brain health monitoring options for caregivers and patients.”
Rhythmlink said: “Dignity Health’s US Patent Number 9,345,418 was protected and commercialized by the Dignity Health Intellectual Property Office and covers an EEG Net with Transmission Capabilities.
“This proprietary technology allows quick and easy collection of EEG data and distribution to medical equipment and health care personnel for analysis and intervention.
“This device is easy to use allowing staff the ability to monitor the brain anywhere anytime maximizing workflow efficiencies and freeing up existing EEG Neurodiagnostic staff, or other cross trained professionals, to be more productive in the patient care setting.
“This technology expands the ability of both large and small hospitals to perform brain health monitoring to identify dangerous patient conditions including subclinical seizure and stroke.
“It even extends the ability to perform brain health monitoring outside of the hospital to ambulances, urgent care clinics and the home.”
Rhythmlink CEO Shawn Regan said: “By adding this patent to our portfolio Rhythmlink continues its quest to make brain health monitoring as ubiquitous as EKG electrodes and equipment have made heart health monitoring over the past 50 years.”